Technical Analysis for SYBX - Synlogic, Inc.

Grade Last Price % Change Price Change
grade B 8.2 0.00% 0.00
SYBX closed unchanged on Friday, May 24, 2019, on approximately normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Flat
See historical SYBX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Gapped Down Weakness 0.00%
200 DMA Resistance Bearish -4.32%
Shooting Star Candlestick Bearish -4.32%

Older signals for SYBX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.
Cancer Biology Disease Diabetes Obesity Inflammatory Bowel Disease Inborn Errors Of Metabolism Synthetic Biology Phenylketonuria Intellectual Disability Newborn Screening Pku Rare Genetic Diseases
Is SYBX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 14.59
52 Week Low 5.75
Average Volume 56,124
200-Day Moving Average 8.8238
50-Day Moving Average 8.0556
20-Day Moving Average 8.32
10-Day Moving Average 8.223
Average True Range 0.5071
ADX 10.42
+DI 19.9011
-DI 19.8645
Chandelier Exit (Long, 3 ATRs ) 7.508699999999999
Chandelier Exit (Short, 3 ATRs ) 8.7313
Upper Bollinger Band 8.9008
Lower Bollinger Band 7.7392
Percent B (%b) 0.4
BandWidth 13.961538
MACD Line 0.0483
MACD Signal Line 0.0594
MACD Histogram -0.0111
Fundamentals Value
Market Cap 133.51 Million
Num Shares 16.3 Million
EPS -9.33
Price-to-Earnings (P/E) Ratio -0.88
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.79
Resistance 3 (R3) 8.77 8.55 8.69
Resistance 2 (R2) 8.55 8.40 8.56 8.65
Resistance 1 (R1) 8.38 8.31 8.27 8.40 8.62
Pivot Point 8.16 8.16 8.11 8.17 8.16
Support 1 (S1) 7.99 8.01 7.88 8.01 7.78
Support 2 (S2) 7.77 7.92 7.78 7.75
Support 3 (S3) 7.60 7.77 7.71
Support 4 (S4) 7.62